Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study
- PMID: 16884976
- DOI: 10.1053/j.jvca.2006.05.012
Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study
Abstract
Objective: The purpose of this study was to evaluate the effects of volatile anesthesia versus total intravenous anesthesia on cardiac troponin release in off-pump coronary artery bypass grafting (OPCAB).
Design: The authors performed a multicenter randomized controlled study to compare cardiac troponin release in patients receiving either volatile anesthetics or total intravenous anesthesia for cardiac surgery on the beating heart, which is an excellent model of human myocardial ischemia.
Setting: Three university hospitals.
Participants: The authors randomly assigned 57 patients to desflurane (volatile anesthetic) and 55 patients to propofol (intravenous anesthetic) in addition to an opiate-based anesthesia for OPCAB.
Interventions: The 2 groups of patients received either desflurane (volatile anesthetic) or propofol in addition to an opiate-based anesthesia for OPCAB. Peak postoperative troponin I release was measured as a marker of myocardial necrosis. Prolonged hospitalization was considered as a secondary outcome.
Measurements and main results: Patient mean age was 69 years, and 82% were men. There was a significant (p < 0.001) reduction in postoperative median (25th-75th percentiles) peak of troponin I in patients receiving volatile anesthetics, 1.2 (0.9-1.9) ng/dL, compared with patients receiving total intravenous anesthesia, 2.7 (2.1-4.0) ng/dL. This myocardial protection resulted in a reduced (p = 0.04) number (percentage) of patients requiring postoperative inotropes, 20 (35%) versus 31 (56%), and a reduced number (percentage) of patients submitted to prolonged hospitalization (> or =7 days), 7 (12%) versus 20 (36%) in the 2 groups (p = 0.005). One patient receiving total intravenous anesthesia died within 30 days of surgery.
Conclusions: Myocardial damage measured by cardiac troponin release could be reduced by volatile anesthetics during OPCAB. Because patients underwent cardiac surgery on the beating heart, these results could have implications for cardiac patients undergoing noncardiac surgery.
Comment in
-
Anesthetic preconditioning: how important is it in today's cardiac anesthesia?J Cardiothorac Vasc Anesth. 2006 Aug;20(4):473-6. doi: 10.1053/j.jvca.2006.05.001. J Cardiothorac Vasc Anesth. 2006. PMID: 16884975 No abstract available.
Similar articles
-
Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.Eur J Anaesthesiol. 2007 Apr;24(4):323-31. doi: 10.1017/S0265021506001931. Epub 2006 Dec 8. Eur J Anaesthesiol. 2007. PMID: 17156509 Clinical Trial.
-
Desflurane versus propofol in patients undergoing mitral valve surgery.J Cardiothorac Vasc Anesth. 2007 Oct;21(5):672-7. doi: 10.1053/j.jvca.2006.11.017. Epub 2007 Feb 22. J Cardiothorac Vasc Anesth. 2007. PMID: 17905272 Clinical Trial.
-
Volatile agents for cardiac protection in noncardiac surgery: a randomized controlled study.J Cardiothorac Vasc Anesth. 2011 Dec;25(6):902-7. doi: 10.1053/j.jvca.2011.06.016. Epub 2011 Aug 27. J Cardiothorac Vasc Anesth. 2011. PMID: 21872490 Clinical Trial.
-
[Myocardial preconditioning in anesthesia: from bench to bedside].Masui. 2009 Mar;58(3):279-87. Masui. 2009. PMID: 19306628 Review. Japanese.
-
Cardiac protection by volatile anesthetics. A review.Minerva Anestesiol. 2009 May;75(5):269-73. Epub 2008 Nov 6. Minerva Anestesiol. 2009. PMID: 18987572 Review.
Cited by
-
Does pharmacological conditioning with the volatile anaesthetic sevoflurane offer protection in liver surgery?HPB (Oxford). 2012 Dec;14(12):854-62. doi: 10.1111/j.1477-2574.2012.00570.x. Epub 2012 Sep 25. HPB (Oxford). 2012. PMID: 23134188 Free PMC article.
-
Bayesian networks identify determinants of outcomes following cardiac surgery in a UK population.BMC Cardiovasc Disord. 2023 Feb 6;23(1):70. doi: 10.1186/s12872-023-03100-6. BMC Cardiovasc Disord. 2023. PMID: 36747123 Free PMC article.
-
An Update on Protein Kinases as Therapeutic Targets-Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases.Int J Mol Sci. 2023 Dec 18;24(24):17600. doi: 10.3390/ijms242417600. Int J Mol Sci. 2023. PMID: 38139428 Free PMC article. Review.
-
Troponin testing after cardiac surgery.HSR Proc Intensive Care Cardiovasc Anesth. 2009;1(3):22-32. HSR Proc Intensive Care Cardiovasc Anesth. 2009. PMID: 23439987 Free PMC article.
-
Myocardial protection in cardiac surgery: a comprehensive review of current therapies and future cardioprotective strategies.Front Med (Lausanne). 2024 Jun 19;11:1424188. doi: 10.3389/fmed.2024.1424188. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38962735 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical